Skip to main content

The Use of Bioinformatics and Chemogenomics in Drug Discovery

  • Chapter
Biopharmaceutical Drug Design and Development
  • 1870 Accesses

Abstract

The Human Genome Project and the emergence of accompanying technology are beginning to transform the drug discovery process. Sequence and structure databases are offering new avenues for the identification of novel genes and drug targets. This communication reviews how bioinformatics and chemogenomics are used for new gene identification, selection of genes or proteins that may be potential drug targets, and the screening of libraries, both in vitro and in silico, for designation of new lead drug compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dougherty, J. D. and Geschwind, D. H. (2002) Subtraction-coupled custom microarray analysis for gene discovery and gene expression studies in the CNS. Chem. Senses 27(3), 293–298.

    Article  CAS  PubMed  Google Scholar 

  2. Friedberg, I. and Godzik, A. (2005) Connecting the protein structure universe by using sparse recurring fragments. Structure 13(8), 1213–1224.

    Article  CAS  PubMed  Google Scholar 

  3. Hann, M. M. and Oprea, T. I. (2004) Pursuing the leadlikeness concept in pharmaceutical research. Curr. Opin. Chem. Biol. 8, 255–263.

    Article  CAS  PubMed  Google Scholar 

  4. Scherf, U., Ross, D. T., Waltham, M., et al. (2000) A gene expression database for the molecular pharmacology of cancer. Nature Genet. 24(3), 236–244.

    Article  CAS  PubMed  Google Scholar 

  5. Ross, D. T., Scherf, U., Eisen, M. B., et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24(3), 227–235.

    Article  CAS  PubMed  Google Scholar 

  6. Dai, Z., Barbacioru, C., Huang, Y., and Sadee, W. (2006) Prediction of anticancer drug potency from expression of genes involved in growth factor signaling. Pharm. Res. 23(2), 336–349.

    Article  CAS  PubMed  Google Scholar 

  7. Schneider, G. and Fechner, U. (2005) Computer-based de novo design of drug-like molecules. Nat. Rev. Drug Discov. 4(8), 649–663.

    Article  CAS  PubMed  Google Scholar 

  8. Ortiz, A. R., Gomez-Puertas, P., Leo-Macias, A., et al. (2006) Computational approaches to model ligand selectivity in drug design. Curr. Top Med. Chem. 6(1), 41–55.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Wu-Pong, S., Shiang, R. (2008). The Use of Bioinformatics and Chemogenomics in Drug Discovery. In: Wu-Pong, S., Rojanasakul, Y. (eds) Biopharmaceutical Drug Design and Development. Humana Press. https://doi.org/10.1007/978-1-59745-532-9_3

Download citation

Publish with us

Policies and ethics